Skip to content
The Nexus
DossierENTITY

stomach-reducing surgery

Coverage of stomach-reducing surgery in the Nexus archive.

Earliest in view: Jul 16 · 10:30 UTCMost recent: Jul 16 · 10:30 UTC
Co-mentioned in this coverage
Amylyx Pharmaceuticalsorganization1avexitidetopic1rare endocrine disordertopic1ALStopic1
Recent coverage
  • HEALTHJul 16 · 10:30 UTCSTAT NEWS
    STAT+: Amylyx nears pivotal endocrine drug study readout

    Amylyx Pharmaceuticals will release results this quarter from a pivotal study of avexitide, a drug targeting severe, uncontrolled drops in blood sugar after stomach-reducing weight-loss surgery. The company previously voluntarily withdrew an ALS drug after a follow-on study showed it lacked efficacy.

stomach-reducing surgery · Dossier · The Nexus